Sarissa Biomedical

About:

Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines.

Website: http://sarissa-biomedical.com/

Twitter/X: SarissaBio

Top Investors: Innovate UK, Mercia Fund Managers, Midlands Engine Investment Fund, Wren Capital, MEIF Proof-of-Concept & Early Stage Fund

Description:

Sarissa is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity / disorders and has a product design platform that offers exquisite sensitivity, coupled with a broad linear range and high levels of accuracy and reproducibility. These biosensors are designed for in vitro and in vivo studies for research and diagnostic applications.